Synthesis and characterization of poly(L-glutamic acid) gadolinium chelate: A new biodegradable MRI contrast agent

Bioconjugate Chemistry

Volumn 15, Issue 6, 2004, Pages 1408-1415

  Wen, Xiaoxia ^a   Jackson, Edward F ^a   Price, Roger E ^a   Kim, E Edmund ^a   Wu, Qingping ^a   Wallace, Sidney ^a   Charnsangavej, Chusilp ^a   Gelovani, Juri G ^a   Li, Chun ^a  

^a UNIVERSITY OF TEXAS MD ANDERSON CANCER CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AMINO ACIDS; BLOOD; CHELATION; CROSSLINKING; GADOLINIUM; MAGNETIC RESONANCE IMAGING; MAMMALS; MOLECULAR WEIGHT DISTRIBUTION;

CONTRAST AGENT; DIETHYLENETRIAMINE PENTA-ACETIC ACIDS; GADOLINIA; GADOLINIUM CHELATES; MAGNETIC RESONANCE IMAGING CONTRAST AGENTS; MONOFUNCTIONAL; POLY-(L-GLUTAMIC ACID); POLY-L-GLUTAMIC ACIDS; RELAXIVITY; SYNTHESISED;

MACROMOLECULES;

6 AMINOBENZYL POLYGLUTAMIC ACID GADOLINIUM PENTETATE; 6 AMINOHEXYL POLYGLUTAMIC ACID GADOLINIUM PENTETATE; CATHEPSIN B; GADOLINIUM CHELATE; NUCLEAR MAGNETIC RESONANCE IMAGING AGENT; POLYGLUTAMIC ACID; UNCLASSIFIED DRUG;

BIODEGRADABILITY; CONFERENCE PAPER; CONTRAST ENHANCEMENT; CONTROLLED STUDY; DIAGNOSTIC IMAGING; DRUG ACCUMULATION; DRUG BLOOD LEVEL; DRUG CLEARANCE; DRUG DEGRADATION; DRUG DISTRIBUTION; DRUG SYNTHESIS; FEMALE; KIDNEY; MOUSE; NONHUMAN; NUCLEAR MAGNETIC RESONANCE IMAGING; SPLEEN;

MURINAE;

EID: 9244248177     PISSN: 10431802     EISSN: None     Source Type: Journal    
DOI: 10.1021/bc049910m     Document Type: Conference Paper

References (30)

1. Kroft, L. J. and de Roos, A. (1999) Blood pool contrast agents for cardiovascular MR imaging. J. Magn. Reson. Imaging 10, 395-403.
2. Bogdanov Jr., A. A., Lewin, M., and Weissleder, R. (1999) Approaches and agents for imaging the vascular system. Adv. Drug Delivery Rev. 37, 279-293.
3. Brasch, R. C. (1992) New directions in the development of MR imaging contrast media. Radiology 183, 1-11.
4. van Bemmel, C. M., Wink, O., Verdonck, B., Viergever, M. A., and Niessen, W. J. (2003) Blood pool contrast-enhanced MRA: Improved arterial visualization in the steady state. IEEE Trans. Med. Imaging 22, 645-652.
5. Su, M. Y., Muhler, A., Lao, X., and Nalcioglu, O. (1998) Tumor characterization with dynamic contrast-enhanced MRI using MR contrast agents of various molecular weights. Magn. Reson. Med. 39, 259-269.
6. van Dijke, C. F., Brasch, R. C., Roberts, T. P., Weidner, N., Mathur, A., Shames, D. M., Mann, J. S., Demsar, F., Lang, P., and Schwickert, H. C. (1996) Mammary carcinoma model: Correlation of macromolecular contrast-enhanced MR imaging characterizations of tumor microvasculature and histologic capillary density. Radiology 198, 813-818.
7. Gossmann, A., Okuhata, Y., Shames, D. M., Helbich, T. H., Roberts, T. P. L., Wendland, M. F., Huber, S., and Brasch, R. C. (1999) Prostate cancer tumor grade differentiation with dynamic contrast-enhanced MR imaging in the rat: Comparison of macromolecular and small-molecular contrast media-preliminary experience. Radiology 213, 265-272.
8. Daldrup, H., Shames, D. M., Wendland, M., Okuhata, Y., Link, T. M., Rosenau, W., Lu, Y., and Brasch, R. C. (1998) Correlation of dynamic contrast-enhanced MR imaging with histologic tumor grade: Comparison of macromolecular and small-molecular contrast media. Am. J. Roentgenol. 171, 941-949.
9. Lauffer, R. B., Parmelee, D. J., Dunham, S. U., Quellet, H. S., Dolan, R. P., Witte, S., McMurry, T. J., and Walovitch, R. C. (1998) Ms-325: Albumin-targeted contrast agent for MR angiography. Radiology 207, 529-538.
10. Adzamli, K., Yablonskiy, D. A., Chicoine, M. R., Won, E. K, Galen, K. P., Zahner, M. C., Woolsey, T. A., and Ackerman, J. J. (2003) Albumin-binding MR blood pool agents as MRI contrast agents in an intracranial mouse glioma model. Magn. Reson. Med. 49, 586-590.
11. Schmiedl, U., Ogan, M., Paajanen, H., Marotti, M., Crooks, L., Brito, A., and Brasch, R. (1987) Albumin labeled with Gd-DTPA as an intravascular, blood pool-enhancing agent for MR imaging: Biodistribution and imaging studies. Radiology 162, 205-210.
12. Schuhmann-Giampieri, G., Schmitt-Willich, H., Frenzel, T., Press, W. R., and Weinmann, H. J. (1991) In vivo and in vitro evaluation of Gd-DTPA-polylysine as a macromolecular contrast agent for magnetic resonance imaging. Invest. Radiol. 26, 969-974.
13. Bogdanov, J., Alexei A., Weissleder, R., and Brady, T. J. (1995) Long-circulating blood pool imaging agents. Adv. Drug Delivery Rev. 16, 335-348.
14. Wang, S. C., Wikstrom, M. G., White, D. L., Klaveness, J., Holtz, E., Rongved, P., Moseley, M. E., and Brasch, R. C. (1990) Evaluation of Gd-DTPA-labeled dextran as an intravascular MR contrast agent: Imaging characteristics in normal rat tissues. Radiology 175, 483-488.
15. Rebizak, R., Schaefer, M., and Dellacherie, E. (1997) Polymeric conjugates of Gd(3-t-)-diethylenetriaminepentaacetic acid and dextran. 1. Synthesis, characterization, and paramagnetic properties. Bioconjugate Chem. 8, 605-610.
16. Wiener, E. C., Brechbiel, M. W., Brothers, H., Magin, R. L., Gansow, O. A., Tomalia, D. A., and Lauterbur, P. C. (1994) Dendrimer-based metal chelates: A new class of magnetic resonance imaging contrast agents. Magn. Reson. Med. 31, 1-8.
17. Adam, G., Neuerburg, J., Spuntrup, E., Muhler, A., Scherer, K., and Gunther, R. W. (1994) Gd-DTPA-cascade-polymer: Potential blood pool contrast agent for MR imaging. J. Magn. Reson. Imaging 4, 462-466.
18. Kobayashi, H. and Brechbiel, M. W. (2003) Dendrimer-based macromolecular mri contrast agents: Characteristics and application. Mol. Imaging 2, 1-10.
19. Kim, Y. H, Choi, B. I., Cho, W. H., Lim, S., Moon, W. K., Han, J. K., Weinmann, H. J., and Chang, K. H. (2003) Dynamic contrast-enhanced MR imaging of vx2 carcinomas after X irradiation in rabbits: Comparison of gadopentetate dimeglumine and a macromolecular contrast agent. Invest. Radiol. 38, 539-549.
20. Unger, E. C., Shen, D., Wu, G., Stewart, L., Matsunaga, T. O., and Trouard, T. P. (1999) Gadolinium-containing copolymeric chelates-a new potential MR contrast agent. Magma 8, 154-162.
21. Gupta, H., Wilkinson, R. A., Bogdanov, A. A., Jr., Callahan, R. J., and Weissleder, R. (1995) Inflammation: Imaging with methoxy poly(ethylene glycol)-poly-l-lysine-DTPA, a long-circulating graft copolymer. Radiology 197, 665-669.
22. Rebizak, R., Schaefer, M., and Dellacherie, E. (1998) Polymeric conjugates of Gd(3+)-diethylenetriaminepentaacetic acid and dextran. 2. Influence of spacer arm length and conjugate molecular mass on the paramagnetic properties and some biological parameters. Bioconjugate Chem. 9, 94-99.
23. Franano, F. N., Edwards, W. B., Welch, M. J., Brechbiel, M. W., Gansow, O. A., and Duncan, J. R. (1995) Biodistribution and metabolism of targeted and nontargeted protein-chelate-gadolinium complexes: Evidence for gadolinium dissociation in vitro and in vivo. Magn. Reson. Imaging 13, 201-214.
24. Li, C. (2002) Poly(1-glutamic acid)- -anticancer drug conjugates. Adv. Drug Delivery Rev. 54, 695-713.
25. Li, C., Yu, D. F., Newman, R. A., Cabral, F., Stephens, L. C., Hunter, N., Milas, L., and Wallace, S. (1998) Complete regression of well-established tumors using a novel water-soluble poly(1-glutamic acid)-paclitaxel conjugate. Cancer Res. 58, 2404-2409.
26. Lu, Z. R., Wang, X., Parker, D. L., Goodrich, K. C., and Buswell, H. R. (2003) Poly(L-glutamic acid) Gd(iii)-DOTA conjugate with a degradable spacer for magnetic resonance imaging. Bioconjugate Chem. 14, 715-719.
27. Hermanson, G. T. (1996) Bioconjugate Techniques, pp 112-113, Academic press, San Diego.
28. Chiu, H. C., Kopeckova, P., Deshmane, S. S., and Kopecek, J. (1997) Lysosomal degradability of poly(alpha-amino acids). J. Biomed. Mater. Res. 34, 381-392.
29. Kishore, B. K, Lambricht, P., Laurent, G., Maldague, P., Wagner, R., and Tulkens, P. M. (1990) Mechanism of protection afforded by polyaspartic acid against gentamicin-induced phospholipidosis. Ii. Comparative in vitro and in vivo studies with poly-1-aspartic, poly-1-glutamic and poly-d-glutamic acids. J. Pharmacol. Exp. Ther. 255, 875-885.
30. Singer, J. W., Baker, B., De Vries, P., Kumar, A., Shaffer, S., Vawter, E., Bolton, M., and Garzone, P. (2003) Poly-(1)-glutamic acid-paclitaxel (ct-2103) [Xyotax], a biodegradable polymeric drug conjugate: Characterization, preclinical pharmacology, and preliminary clinical data. Adv. Exp. Med. Biol. 519, 81-99.